Uric acid disposition during intermittent chemotherapy of pulmonary tuberculosis with regimens containing pyrazinamide & rifampicin.
D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D011718:Pyrazinamide / Q000008:administration & dosage*; D012293:Rifampin / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000378:metabolism; D014527:Uric Acid / Q000378:metabolism*
D014527:Uric Acid; D011718:Pyrazinamide; D012293:Rifampin